The Prescription pattern among dermatologist for hyper-pigmentation drugs

Shahwaz AhsanMBA Pharmaceutical2ndSemester(2012-

14)Department of

Management, Jamia Hamdard

Under the supervision ofDr. Shibu John ,Faculty Supervisor of FMIT ,Jamia Hamdard

Mr. Nabeel Anwar

Product Manager

Abbott HealthCare

History of the companyLiterature reviewResearch methodologyFindings & Data analysisConclusionSuggestionsLimitations

Contents

Founded in 1888, by a young Chicago based physician, Dr. Wallace Calvin

Abbott. The organization has been devoted to discovering new

medicines, new technologies and new ways to manage health Today.

Abbott is a worldwide broad based healthcare company whose products and technologies are growing rapidly.

History of the company

Fast factsChairman and CEO: Miles D. WhiteCorporate Headquarters: North suburban Chicago, Illinois, USANumber of Employees: Approximately 70,000 worldwideRevenue: INR 121,000 Cr.2012 Income after tax: INR 31,500 Cr. Presence: 150+ countries

Chairman and CEO: Miles D. WhiteCorporate Headquarters: North suburban Chicago,USANumber of Employees: Approximately 70,000 worldwideRevenue: INR 121,000 Cr.2012 Income after tax: INR 31,500 Cr. Working in: 150+ countries

Fast facts

Product of the company

The Abbott pharma having more than 400 brands, a strong infrastructure and large scale operations with therapeutic areas that include: women's health, neuropsychiatry, hepatic care,metabolics, pain, gastroenterology and cardiovascular.

Thyronorm for hypothyroidism. Tibet for diabetes.

Hyper-pigmentation is a common, usually harmless condition in which patches of skin become darker in color than the normal surrounding skin.

Types of hyper-pigmentation- Melasma,post-inflamatory hyperpigmentation,periorbital hyper-pigmentation etc

Causes- There are various causes of hyper-pigmentation, including over production of melanin or pigment overexposure to the sun ,hormonal changes in the body.

Literature review

Treatment option-A number of therapies are available for the treatment of hyper-pigmentation.

Hyper-pigmentation occurs due to overproduction of malanin they try to reduce melanin from the skin.

Hormonal changes is another cause of hyper-pigmentation so sometimes doctors try to stable hormone in the body by the help of chemical pills.

Laser and surgery is the another treatment option for

hyper-pigmentation

Cont.

My objective of the study was “to determine the Prescription pattern of dermatologist for the hyper-pigmentation drugs in Delhi Region.

My another objective was that to know the numbers of patients,convenient cost and what is the duration of disease of hyper-pigmentation.

Objectives

This study was carried out for the prescription Pattern of

dermatologist.I worked on questionnaire for market survey I

also earned that how to interact with doctors.

Source of primary data: Primary data is a type

of information

that is obtained directly from first-hand sources

by means of

surveys, observation or experimentation.

Research methodology

I collected my primary data through the one to one interaction and discussion with various dermatologists,trough the questionnaire which was both close and open ended .

Secondary data-The data that has been already collected by readily available from other sources.I also collected my secondary data through annual reports of the company, newspaper, magazines, internet and sample material about latest treatments and practices in periorbital symptoms.

Cont.

Sampling method: Random sampling Sample Size: 80  Research tools: Questionnaire

 Area covered: South Delhi

Cont.

Data analysis & findings

36%

38%

23%4%

0-10 percent10-20 percent20-30 percent30-40 percent

Total patients of hyperpigmentation out of 100

Chart no-1

Kojic acidHydroquinoneSteroidGlicolic acid

Chart no.2

Most preferred drug for the treatment of hyperpigmentation

47.5%

21.2%

18.8%

12.2%

melasma port wine stain vitiligo albinism0

5

10

15

20

25

30

35

Series1

Axis Y -Common disease

Axis

X-N

um

ber

of

pati

ents

30

20 23

7

Chart no.2

Most common type of hyper-pigmentation

0-3 months

3-6 months

6-9 months

9-12 months

0

5

10

15

20

25

30

30

20

23

7

Duration of therapy for the treatment of hyperpigmentation

Chart no.3

Hypopigmentation Itching Atrophy vomiting0

5

10

15

20

25

30

18

29

5

28

Adverse effect of the drug used in hyper-pigmentation

Chart no-5

First of all I have started my study from questionnaire. I got questionnaire from Abbott healthcare and afterthat I generated

all the question in multiple form.I have used “questionnaire” in my research tools.

After completing this task I have targeted to dermatologist and

visited them through one to one interaction . when I visited them I collected my primary data from dermatologist and secondary data from

newspaper,magazines books and internet. I have generally taken random sampling and the size of

sampling was 80,so it was ultimate experience for me.

Conclusions

Suggestions

Abbott healthcare must make a survey about the competitors in the the market for the hyper-pigmentation product.

They need to visit various chemist shops to know the price of the different types of hyper-pigmentation product offering by the competitors

Area Limitation :I visited only in south Delhi so the area was so limited due to the limitation of area, I Could ‘nt know what is the view of dermatologist who runs their clinics in other area like north and west Delhi. 

Sample size :The sample size was little bit small, I visited around 80 dermatologist so I can not justify that all the dermatologist comes under this circumstances.

Lack of experience: I had no so much experience to the interaction with the doctors so initially I was reluctant to ask the questions from them.

Limitations